SCHEMBL17154455

SCHEMBL17154455

CC(=O)Nc1ccc2c(C)c3ccccc3nc2c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 10/20 0.68
KDM4E B2RXH2 8/20 0.68
MEN1 O00255 8/20 0.68
MAPT P10636 6/20 0.68
NPC1 O15118 5/20 0.68
RAB9A P51151 4/20 0.68
PABPC1 P11940 1/20 0.68
SMN1; SMN2 Q16637 3/20 0.61
POLB P06746 2/20 0.61
LMNA P02545 2/20 0.61
KDM1A O60341 1/20 0.61
MITF O75030 1/20 0.61
RAD52 P43351 1/20 0.61
RECQL P46063 1/20 0.61
NPSR1 Q6W5P4 1/20 0.61
L3MBTL1 Q9Y468 1/20 0.61
GLA P06280 1/20 0.58
TNNI3 P19429 1/20 0.58
TNNT2 P45379 1/20 0.58
TNNC1 P63316 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17154375 0.87 KMT2A (0.66) KMT2AKDM4EMEN1MAPTNPC1
SCHEMBL4159315 0.87 KDM4E (0.66) KMT2AKDM4EMEN1MAPTNPC1
SCHEMBL2374293 0.81 MAPT (1.00) KMT2AKDM4EMEN1MAPTNPC1
SCHEMBL17154362 0.80 KDM1A (0.74) KMT2AKDM4EMEN1MAPTNPC1
SCHEMBL4163695 0.78 KDM4E (0.65) KMT2AKDM4EMEN1MAPTNPC1
SCHEMBL4163110 0.78 KMT2A (0.66) KMT2AKDM4EMEN1MAPTNPC1
SCHEMBL6080450 0.76 KDM4E (0.51) KMT2AKDM4EMEN1MAPTNPC1
SCHEMBL29226582 0.76 KMT2A (0.68) KMT2AKDM4EMEN1MAPTNPC1
SCHEMBL17154400 0.76 KDM1A (1.00) KMT2AKDM4EMEN1MAPTSMN1; SMN2
SCHEMBL3776520 0.76 KMT2A (0.65) KMT2AKDM4EMEN1MAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015153535-A1 NOVEL HDMX INHIBITORS AND THEIR USE FOR CANCER TREATMENT MiRx Pharmaceuticals, LLC (US) 2015-10-08 WO disclosed